Ateş Kara - Infectious Diseases

Author Information

Ateş Kara is a distinguished expert in the field of Infectious Diseases, affiliated with the Hacettepe University Faculty of Medicine, Department of Pediatrics, Unit of Infectious Diseases, in Ankara, Turkey. He has made significant contributions to the understanding and management of infectious diseases, particularly in pediatric populations. His research has been pivotal in advancing knowledge on COVID-19 and its impact on children.

Research Contributions

Ateş Kara has contributed extensively to the study of COVID-19, with a focus on pediatric cases. His research includes the investigation of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, the persistence of SARS-CoV-2 antibodies, and the impact of the pandemic on vaccination rates in Turkey. His work has provided valuable insights into the clinical features and epidemiological aspects of COVID-19 in children, as well as the management of COVID-19 in vulnerable populations such as children with cancer or those who have undergone stem cell transplants.

Aliases

Ateş Kara is also known by several aliases, including A A Kara, A. Kara, A Kara, and Atış Kara. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	2327
h-index	24
Paper Count	249

Publications:

Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study).

DOI: 10.1111/jpc.15913

Year: 2022

COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group

DOI: 10.1007/s00431-022-04390-2

Year: 2022

Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection

DOI: 10.1007/s11845-021-02716-x

Year: 2022

The effectiveness of topical 1% lidocaine with systemic oral analgesics for ear pain with acute otitis media.

DOI: 10.1016/j.ijporl.2022.111116

Year: 2022

Comparison of SARS-CoV-2 Antibodies and Six Immunoassays in Pediatric and Adult Patients 12 Weeks After COVID-19

DOI: 10.7759/cureus.22195

Year: 2022

Epidemiological, Clinical, and Laboratory Features of Children With COVID-19 in Turkey

DOI: 10.3389/fped.2021.631547

Year: 2021

Alteration in vaccination rates and an evaluation of physicians’ perceptions of the possible impact of the SARS-CoV-2 pandemic on childhood vaccinations in Ankara, Turkey

DOI: 10.1080/21645515.2021.1923345

Year: 2021

COVID‐19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study

DOI: 10.1002/pbc.28915

Year: 2021

Multicentric Castleman Disease in a DOCK8 Deficient Patient with Orf Virus Infection

DOI: 10.22541/au.162429209.93699758/v1

Year: 2021

Multicentric Castleman disease in a DOCK8‐deficient patient with Orf virus infection

DOI: 10.1111/pai.13666

Year: 2021

Why Are Vaccinations Important in Infectious Diseases?

How Often Should You Get a Health Check-Up?

Can West Nile Virus be Prevented?

What is Pink Eye?

When Should One Seek Medical Attention for Fatigue?

What is Immunotherapy?

What Are the Risks Associated with Throat Swabs?

Which Diseases Spread Through Airborne Transmission?

What are the Risks of Untreated Infections During Pregnancy?

How Do Fungi Infect Hosts?

Partnered Content Networks

Relevant Topics